Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions. (clinicaltrials.gov) - Jun 13, 2026 - P1 | N=36 | Recruiting | Sponsor: Valenta Pharm JSC New P1 trial • Infectious Disease • Influenza • Respiratory Diseases
|